OncoMed Pharmaceuticals Inc Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
OncoMed Pharmaceuticals Inc reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$8.10 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2018-12-31 was -$4.67M, a 149.31% decline year-over-year.
- OncoMed Pharmaceuticals Inc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2018-09-30 was $6.12M.
- OncoMed Pharmaceuticals Inc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2017-12-31 was $9.46M.
- OncoMed Pharmaceuticals Inc net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2017-09-30 was -$10.69M.
- OncoMed Pharmaceuticals Inc net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$8.10M.
- OncoMed Pharmaceuticals Inc net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was -$39.06M.
- OncoMed Pharmaceuticals Inc net income (loss), including portion attributable to noncontrolling interest for fiscal 2016 was -$103.10M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.45M derived: sum of 2 quarters · filed 2019-03-07 | -$8.10M 10-K · filed 2019-03-07 | |
| 2018-09-30 | $6.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$3.44M 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | -$9.55M 10-Q · filed 2018-08-02 | |||
| 2017-12-31 | $9.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$1.23M derived: sum of 2 quarters · filed 2019-03-07 | -$39.06M 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$10.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$48.52M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$37.83M 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | -$103.10M 10-K · filed 2019-03-07 |